Tsafrir S Mor1. 1. School of Life Sciences and The Biodesign Institute, Arizona State University, P.O. Box 874501, Tempe, AZ, 85287-4501, USA. tsafrir.mor@asu.edu.
Abstract
OBJECTIVES: This short commentary examines the factors that led to Food and Drug Administration's approval of the first plant-derived biologic. RESULTS: In 2012, the first plant-derived protein pharmaceutical (biologic) was approved for commercial use in humans. The product, a recombinant form of human β-glucocerebrosidase marketed as ELELYSO, was developed by Protalix Biotherapeutics (Carmiel, Israel). The foresight to select this particular therapeutic product for development, flawless production pipeline, and serendipity seem to provide the key in explaining how ELELYSO became the first plant-derived biologic to achieve approval by Food and Drug Administration. CONCLUSIONS: While the circumstances that enabled Protalix and its scientists to become the first to arrive at this historic milestone are perhaps unique, it is anticipated that more biologics will follow suit in winning regulatory endorsement.
OBJECTIVES: This short commentary examines the factors that led to Food and Drug Administration's approval of the first plant-derived biologic. RESULTS: In 2012, the first plant-derived protein pharmaceutical (biologic) was approved for commercial use in humans. The product, a recombinant form of human β-glucocerebrosidase marketed as ELELYSO, was developed by Protalix Biotherapeutics (Carmiel, Israel). The foresight to select this particular therapeutic product for development, flawless production pipeline, and serendipity seem to provide the key in explaining how ELELYSO became the first plant-derived biologic to achieve approval by Food and Drug Administration. CONCLUSIONS: While the circumstances that enabled Protalix and its scientists to become the first to arrive at this historic milestone are perhaps unique, it is anticipated that more biologics will follow suit in winning regulatory endorsement.
Authors: Edward D Bashaw; Shiew-Mei Huang; Timothy R Coté; Anne R Pariser; Christine E Garnett; Gilbert Burckart; Lei Zhang; Angela Y Men; Christine D Le; Rosane Charlab; Jogaro V Gobburu; Lawrence J Lesko Journal: Nat Rev Drug Discov Date: 2011-10-31 Impact factor: 84.694
Authors: Maria J Ferraz; Wouter W Kallemeijn; Mina Mirzaian; Daniela Herrera Moro; Andre Marques; Patrick Wisse; Rolf G Boot; Lianne I Willems; H S Overkleeft; J M Aerts Journal: Biochim Biophys Acta Date: 2013-11-13
Authors: Yoseph Shaaltiel; Daniel Bartfeld; Sharon Hashmueli; Gideon Baum; Einat Brill-Almon; Gad Galili; Orly Dym; Swetlana A Boldin-Adamsky; Israel Silman; Joel L Sussman; Anthony H Futerman; David Aviezer Journal: Plant Biotechnol J Date: 2007-05-24 Impact factor: 9.803
Authors: Xiangguo Qiu; Gary Wong; Jonathan Audet; Alexander Bello; Lisa Fernando; Judie B Alimonti; Hugues Fausther-Bovendo; Haiyan Wei; Jenna Aviles; Ernie Hiatt; Ashley Johnson; Josh Morton; Kelsi Swope; Ognian Bohorov; Natasha Bohorova; Charles Goodman; Do Kim; Michael H Pauly; Jesus Velasco; James Pettitt; Gene G Olinger; Kevin Whaley; Bianli Xu; James E Strong; Larry Zeitlin; Gary P Kobinger Journal: Nature Date: 2014-08-29 Impact factor: 49.962
Authors: Rainer Fischer; Tanja Holland; Markus Sack; Stefan Schillberg; Eva Stoger; Richard M Twyman; Johannes F Buyel Journal: Adv Biochem Eng Biotechnol Date: 2021 Impact factor: 2.635
Authors: Katherine E Larrimore; I Can Kazan; Latha Kannan; R Player Kendle; Tameem Jamal; Matthew Barcus; Ashini Bolia; Stephen Brimijoin; Chang-Guo Zhan; S Banu Ozkan; Tsafrir S Mor Journal: Sci Rep Date: 2017-09-05 Impact factor: 4.379
Authors: Bonnie C Wintle; Christian R Boehm; Catherine Rhodes; Jennifer C Molloy; Piers Millett; Laura Adam; Rainer Breitling; Rob Carlson; Rocco Casagrande; Malcolm Dando; Robert Doubleday; Eric Drexler; Brett Edwards; Tom Ellis; Nicholas G Evans; Richard Hammond; Jim Haseloff; Linda Kahl; Todd Kuiken; Benjamin R Lichman; Colette A Matthewman; Johnathan A Napier; Seán S ÓhÉigeartaigh; Nicola J Patron; Edward Perello; Philip Shapira; Joyce Tait; Eriko Takano; William J Sutherland Journal: Elife Date: 2017-11-14 Impact factor: 8.140